Deji Suolang1, Bridget J Chen1, Nae-Yuh Wang2,3,4,5, Rebecca F Gottesman6, Roland Faigle1,5. 1. Departments of Neurology (D.S., B.J.C., R.F.), Johns Hopkins University School of Medicine, Baltimore, MD. 2. Medicine (N.-Y.W.), Johns Hopkins University School of Medicine, Baltimore, MD. 3. Biostatistics (N.-Y.W.), Johns Hopkins University School of Medicine, Baltimore, MD. 4. Epidemiology (N.-Y.W.), Johns Hopkins University School of Medicine, Baltimore, MD. 5. Johns Hopkins Center for Health Equity, Baltimore, MD (N.-Y.W., R.F.). 6. Stroke Branch, National Institute of Neurological Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, MD (R.F.G.).
Abstract
BACKGROUND AND PURPOSE: Intravenous thrombolysis (IVT) after ischemic stroke is underutilized in racially/ethnically minoritized groups. We aimed to determine the regional and geographic variability in racial/ethnic IVT disparities in the United States. METHODS: Acute ischemic stroke admissions between 2012 and 2018 were identified in the National Inpatient Sample. Multivariable logistic regression was used to test the association between IVT and race/ethnicity, stratified by geographic region and controlling for demographic, clinical, and hospital characteristics. RESULTS: Of the 545 509 included cases, 47 031 (8.6%) received IVT. Racially/ethnically minoritized groups had significantly lower adjusted odds of IVT compared with White people in the South Atlantic region (odds ratio [OR], 0.86 [95% CI, 0.82-0.91]), the East North Central region (OR, 0.91 [95% CI, 0.85-0.97]) and the Pacific region (OR, 0.90 [95% CI, 0.85-0.96]). In the South Atlantic region, IVT use in racial/ethnic minority groups was below the national average of all racial/ethnic minority patients (P=0.002). Compared with White patients, Black patients had lower odds of IVT in the Middle Atlantic region (OR, 0.84 [95% CI, 0.78-0.91]), the South Atlantic region (OR, 0.78 [95% CI, 0.74-0.82]), and the East North Central region (OR, 0.86 [95% CI, 0.79-0.93]). In the South Atlantic region, this difference was below the national average for Black people (P<0.001). Hispanic patients had significantly lower use of IVT only in the Pacific region (OR, 0.92 [95% CI, 0.85-0.99]), while Asian/Pacific Islander patients had lower odds of IVT in the Mountain (OR, 0.76 [95% CI, 0.59-0.98]) and Pacific region (OR, 0.89 [95% CI, 0.82-0.97]). CONCLUSIONS: Racial/ethnic disparities in IVT use in the United States vary by region. Geographic hotspots of lower IVT use in racially/ethnically minoritized groups are the South Atlantic region, driven predominantly by lower use of IVT in Black patients, and the East North Central and Pacific regions.
BACKGROUND AND PURPOSE: Intravenous thrombolysis (IVT) after ischemic stroke is underutilized in racially/ethnically minoritized groups. We aimed to determine the regional and geographic variability in racial/ethnic IVT disparities in the United States. METHODS: Acute ischemic stroke admissions between 2012 and 2018 were identified in the National Inpatient Sample. Multivariable logistic regression was used to test the association between IVT and race/ethnicity, stratified by geographic region and controlling for demographic, clinical, and hospital characteristics. RESULTS: Of the 545 509 included cases, 47 031 (8.6%) received IVT. Racially/ethnically minoritized groups had significantly lower adjusted odds of IVT compared with White people in the South Atlantic region (odds ratio [OR], 0.86 [95% CI, 0.82-0.91]), the East North Central region (OR, 0.91 [95% CI, 0.85-0.97]) and the Pacific region (OR, 0.90 [95% CI, 0.85-0.96]). In the South Atlantic region, IVT use in racial/ethnic minority groups was below the national average of all racial/ethnic minority patients (P=0.002). Compared with White patients, Black patients had lower odds of IVT in the Middle Atlantic region (OR, 0.84 [95% CI, 0.78-0.91]), the South Atlantic region (OR, 0.78 [95% CI, 0.74-0.82]), and the East North Central region (OR, 0.86 [95% CI, 0.79-0.93]). In the South Atlantic region, this difference was below the national average for Black people (P<0.001). Hispanic patients had significantly lower use of IVT only in the Pacific region (OR, 0.92 [95% CI, 0.85-0.99]), while Asian/Pacific Islander patients had lower odds of IVT in the Mountain (OR, 0.76 [95% CI, 0.59-0.98]) and Pacific region (OR, 0.89 [95% CI, 0.82-0.97]). CONCLUSIONS: Racial/ethnic disparities in IVT use in the United States vary by region. Geographic hotspots of lower IVT use in racially/ethnically minoritized groups are the South Atlantic region, driven predominantly by lower use of IVT in Black patients, and the East North Central and Pacific regions.
Authors: Amie W Hsia; Dorothy F Edwards; Lewis B Morgenstern; Jeffrey J Wing; Nina C Brown; Regina Coles; Sarah Loftin; Andrea Wein; Sara S Koslosky; Sabiha Fatima; Brisa N Sánchez; Ali Fokar; M Chris Gibbons; Nawar Shara; Annapurni Jayam-Trouth; Chelsea S Kidwell Journal: Stroke Date: 2011-06-30 Impact factor: 7.914
Authors: Lee H Schwamm; Mathew J Reeves; Wenqin Pan; Eric E Smith; Michael R Frankel; DaiWai Olson; Xin Zhao; Eric Peterson; Gregg C Fonarow Journal: Circulation Date: 2010-03-22 Impact factor: 29.690
Authors: Sarah Song; Li Liang; Gregg C Fonarow; Eric E Smith; Deepak L Bhatt; Roland A Matsouaka; Ying Xian; Lee H Schwamm; Jeffrey L Saver Journal: JAMA Neurol Date: 2019-04-01 Impact factor: 18.302
Authors: Keith Churchwell; Mitchell S V Elkind; Regina M Benjamin; April P Carson; Edward K Chang; Willie Lawrence; Andrew Mills; Tanya M Odom; Carlos J Rodriguez; Fatima Rodriguez; Eduardo Sanchez; Anjail Z Sharrief; Mario Sims; Olajide Williams Journal: Circulation Date: 2020-11-10 Impact factor: 29.690
Authors: Hugo J Aparicio; Brendan G Carr; Scott E Kasner; Michael J Kallan; Karen C Albright; Dawn O Kleindorfer; Michael T Mullen Journal: J Am Heart Assoc Date: 2015-10-14 Impact factor: 5.501
Authors: Ralph L Sacco; Hannah Gardener; Kefeng Wang; Chuanhui Dong; Maria A Ciliberti-Vargas; Carolina M Gutierrez; Negar Asdaghi; W Scott Burgin; Olveen Carrasquillo; Enid J Garcia-Rivera; Ulises Nobo; Sofia Oluwole; David Z Rose; Michael F Waters; Juan Carlos Zevallos; Mary Robichaux; Salina P Waddy; Jose G Romano; Tatjana Rundek Journal: J Am Heart Assoc Date: 2017-02-14 Impact factor: 5.501
Authors: Renee Y Hsia; Delphine Huang; N Clay Mann; Christopher Colwell; Mary P Mercer; Mengtao Dai; Matthew J Niedzwiecki Journal: JAMA Netw Open Date: 2018-11-02